Oxford's trial involved 300 children and teenagers, 200 of whom would receive the AstraZeneca vaccine and the rest given a "placebo" meningitis vaccine shot
Oxford's trial involved 300 children and teenagers, 200 of whom would receive the AstraZeneca vaccine and the rest given a "placebo" meningitis vaccine shot